Science and Technology Perspective

 
 

  • Sep 08 2023 This Week in Cardiology   ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week’s podcast.
  • Heart Failure Guidelines Update: What the ESC Got Right   Heart failure specialist Dr Ileana Piña discusses what she likes about the 2023 ESC focused update to the heart failure guidelines.
  • Left-Digit Bias and Other Random Acts of Medicine   A new book reveals how chance can change the course of a person's health, life, and death.
  • Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  • S2 Episode 6: Neoadjuvant Therapy and Renal Cell Carcinoma   Drs Sumanta Pal and Jose A. Karam discuss neoadjuvant therapy in renal cell carcinoma, including TKIs, IO, and the need for more studies to explore the role of neoadjuvant therapy in RCC.
  • Journal Summary: Vitiligo Journal Summaries provide a quick review of recent journal articles with current or near-term clinical significance. Catch up on key research on vitiligo from the past year.
  • Do You P.U.I.? In case you are looking for a place to park your discretionary funds, I have recently learned that nonalcoholic beer is the fastest-growing segment of the beer industry.
  • Episode 3: How Do You Optimize Neoadjuvant Therapy Selection?   Join experts Drs Kevin Kalinsky and Priyanka Sharma as they discuss their current approach to neoadjuvant therapy in triple-negative breast cancer and how the SCARLET trial might change that.
  • The New Normal in Body Temperature   Are humans more cold-blooded than we have always believed? F. Perry Wilson reviews a study of "normal" oral temperatures in adults.
  • Episode 5: Liver-Directed Therapy for Colorectal Cancer   How do you know if your patient will benefit from liver-directed therapy for colorectal cancer? Join experts Drs Benjamin Schlechter and Ammar Sarwar as they discuss.
  • Sep 01 2023 This Week in Cardiology   ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John Mandrola, MD, discusses in this week’s podcast.
  • The Most Important Study From ESC If you treat patients, no trial at ESC is more important, according to John Mandrola, MD. The results of FRAIL-AF demonstrate the value of humility in science and the practice of evidence-based medicine.
  • Metabolic Inflexibility: More Than 'Energy In, Energy Out' How is energy used? Metabolic flexibility is the body's ability to adjust to changes in energy, and it plays an important role in people with diabetes and obesity.
  • Can We Be Too Efficient? Every day I look for ways to go faster. This is not so I can be out the door by 3. Rather, it's simply to make it through the day without having to log on after we put the kids to bed at night.
  • Dealing With Avian and Variant Influenza A Infections The CDC's Tim Uyeki, MD, discusses trends in avian influenza A and variant influenza A viruses, as well as guidance on prevention and treatment.
  • Really? Cancer Screening Doesn't Save Lives?   You might have a hard time believing that all this cancer screening is for nothing. See what Perry thinks.
  • Infographic: Realities of Working as an Employed Physician Doctors who work for healthcare organizations and other employers tell of their happiness with their salaries, the importance of respect for their contributions, and where they would go for a new job.
  • Episode 4: The Past, Present, and Future of Chronic Myeloid Leukemia   Drs Michael J. Mauro and Michael W. Deininger discuss the evolution of chronic myeloid leukemia, better access to treatment, improved global cure rates, and a clearer definition of the word cure.
  • ESC 2023 Pulsed Field Ablation for AF Underwhelming in ADVENT Pulsed field ablation did not live up to the hype and enthusiasm of European colleagues, according to this US-based electrophysiologist, but the results of ADVENT are likely sufficient for FDA approval.
  • Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Timing Treatment   NYC thoracic specialists discuss how patients enter the care of their multidisciplinary team and what happens after the initial appointment.